Aether Announces Residency at JLABS @ QB3

Will utilize resources to seize control of 3D bioprinter and bio-ink markets

(Left to Right) QB3@953 Director Robert Blazej with Aether CEO Ryan Franks, Marissa Buell, Science Director Karen Dubbin, and Sanjay Srinivas. (Photo: Business Wire)

SAN FRANCISCO--()--Today Aether, a San Francisco-based life sciences technology company, is pleased to announce it is now a resident company at Johnson & Johnson Innovation, JLABS @ QB3, located in the University of California’s QB3 @ 953 Indiana Street facility. Aether will make use of the cutting-edge research facilities including everything from equipment to expertise for the Company’s research and development of advanced biomaterials, 3D bioprinting technologies, and upcoming projects.

Aether CEO Ryan Franks said, “The demand for our product has become overwhelming, so we have to scale up immediately to capitalize on this unprecedented opportunity to control the bioprinting market. As Aether prepares to launch a rapidly expanding suite of disruptive technologies, these resources will help us pursue this opportunity quickly, and at scale.”

Additionally, Aether Science Director Dr. Karen Dubbin has proved to be a valuable innovator in the field of materials science at MIT and Stanford. She played a large role in establishing Stanford’s bio-ink research program, and now Dr. Dubbin will spearhead Aether’s biomaterials research at the incubator.

Aether is in a privileged position to benefit from the resources of Johnson and Johnson Innovation, JLABS, as well as the University of California’s hub for innovation and entrepreneurship in the life sciences, QB3.

About Aether

Aether empowers researchers to make history with the first 3D bioprinter truly capable of printing structures with tissue-scale complexity. Aether uses Computer Vision to automate the most difficult elements of 3D bioprinting, and allows users to simultaneously print with up to 24 materials including filaments, liquids, viscous pastes and gels.

Aether’s second San Francisco location at 953 Indiana Street will serve as a scientific research center to complement the hardware and software research at Aether’s 1337 Mission Street headquarters. Visit our website at:

Aether’s company profile can be found on the Johnson and Johnson Innovation website here:

Aether is also listed as QB3’s latest company here:


Stacey Meza

Release Summary

Aether announces residency at Johnson and Johnson Innovation's JLABS at QB3, where the Aether 1 3D Bioprinter will be used for bioprinting research.


Stacey Meza